Sunshine Biopharma Inc (SBFM)

[snpwfan]

Read the PRs. They speak for themselves. I am not worried about the SEC in terms of Covid claims by the company.

Sunshine Bio launches COVID-19 treatment mice study

Feb. 10, 2021 8:48 AM ETSunshine Biopharma, Inc. (SBFM)By: Mamta Mayani, SA

Sunshine Biopharma (OTCPK:SBFM) has initiated a transgenic mice study of its COVID-19 treatment that has been under development since May 2020.

The mice studies are currently underway at the University of Georgia, College of Pharmacy.

The mice being used in the study have been genetically engineered to express the human angiotensin-converting enzyme 2 (hACE2) transmembrane protein in their lungs making them susceptible to infection by SARS-CoV-2.

The goal of the study is to determine if SBFM's protease inhibitors will protect the hACE2-transgenic mice from disease progression and death.

"Should these mice studies prove successful, we plan to submit the results to the FDA for authorization to conduct testing on actual COVID-19 patient volunteers in a Phase I clinical trial setting," said Dr. Steve Slilaty, CEO.

Last week, Sunshine Biopharma inked license agreement with the University of Georgia for COVID-19 compounds.